Valuation: Biogen Inc.

Market Cap 3.08TCr 2.67TCr 2.49TCr 2.29TCr 4.32TCr 2,92900Cr 4.37TCr 29TCr 11TCr 1,46500Cr 12TCr 11TCr 4,85300Cr P/E 2026 *
37.9x
P/E 2027 * 18.4x
Enterprise Value 3.59TCr 3.11TCr 2.9TCr 2.66TCr 5.03TCr 3,41200Cr 5.09TCr 34TCr 13TCr 1,70700Cr 13TCr 13TCr 5,65400Cr EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.14x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week-0.96%
Current month+2.11%
1 month-0.59%
3 months+9.57%
6 months+11.80%
Current year+17.75%
1 week 199.58
Extreme 199.58
212.18
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 127
Extreme 127
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06/26 Free

Director

1,505 0.0010%
13/02/26 Free

Head of Human Resources

8,025 0.0055%
13/02/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-0.96%+55.94%-23.60% 3.08TCr
+0.94%+10.56%+34.91%-0.76% 7.6TCr
+2.64%-8.65%+22.67%+186.79% 4.9TCr
+1.02%-3.74%-7.47%+21.83% 4.79TCr
+1.42%+9.32%-50.68%-50.72% 4.34TCr
-0.32%-5.15%+55.11%+85.73% 2.44TCr
-1.09%+3.67%+105.64%-44.18% 2.28TCr
+4.15%+0.44%-2.80%+175.30% 1.92TCr
-0.09%-1.70%+66.88%+165.25% 1.6TCr
+1.05%-6.85%+60.29%+117.79% 1.59TCr
Average +0.91%-1.38%+34.05%+63.34% 3.45TCr
Weighted average by Cap. +1.04%+0.26%+25.06%+46.91%

Financials

2026 *2027 *
Net sales 1.04TCr 902.72Cr 841.5Cr 773.96Cr 1.46TCr 99TCr 1.48TCr 9.89TCr 3.88TCr 50TCr 3.91TCr 3.83TCr 1,64200Cr 1.06TCr 920.22Cr 857.81Cr 788.96Cr 1.49TCr 1,01000Cr 1.51TCr 10TCr 3.96TCr 51TCr 3.99TCr 3.9TCr 1,67400Cr
Net income 95Cr 83Cr 77Cr 71Cr 133.61Cr 9.06TCr 135.1Cr 904.22Cr 354.89Cr 4.53TCr 357.95Cr 350.06Cr 15TCr 189.92Cr 164.49Cr 153.34Cr 141.03Cr 266.24Cr 18TCr 269.22Cr 1.8TCr 707.22Cr 9.04TCr 713.31Cr 697.59Cr 30TCr
Net Debt 508.12Cr 440.08Cr 410.24Cr 377.31Cr 712.3Cr 48TCr 720.26Cr 4.82TCr 1.89TCr 24TCr 1.91TCr 1.87TCr 80TCr 256.62Cr 222.25Cr 207.18Cr 190.55Cr 359.73Cr 24TCr 363.75Cr 2.43TCr 955.56Cr 12TCr 963.8Cr 942.55Cr 40TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/26/06 $207.21 -0.59% 4,14,511
04/26/04 $208.45 +3.29% 12,05,704
03/26/03 $201.82 -0.56% 9,40,993
31/26/31 $202.95 -2.40% 10,62,258
30/26/30 $207.93 -0.62% 8,92,938
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
208.45USD
Average target price
235.32USD
Spread / Average Target
+12.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock